What is the difference between 503A and 503B compound pharmacies
Budget constraints and rising prescription costs have motivated insurers to impose stricter prior authorization requirements, limiting access to prevent rapid increases in claims
What to do: Avoid caffeine late in the day, keep a regular bedtime, and limit screen time before sleep
CJC-1295 and Ipamorelin are both synthetic peptides that stimulate the release of growth hormone (GH) from the pituitary gland
The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026
Thus, the inability to account for inhibition of IGF-2 binding to the IGF-1R is an important limitation in this study, which should be considered when assessing outcomes from human trials using IGF-1R mAbs